| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
3 companies
Biotech Target N V is a 10% Owner at MGNX with holdings across 3 companies. Recent SEC Form 4 filings include 10 buys and 0 sells.
Estimated insider holdings value: $72.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 23, 2019 | ESPR Esperion Therapeutics, Inc. | 10% Owner | Buy | 50,000 | $42.65 | $2,132,565.00 | +1.4% | |
| Mar 14, 2019 | ESPR Esperion Therapeutics, Inc. | 10% Owner | Buy | 50,000 | $49.89 | $2,494,355.00 | +1.4% | |
| Jan 4, 2019 | ESPR Esperion Therapeutics, Inc. | 10% Owner | Buy | 80,000 | $41.29 | $3,303,256.00 | +2.4% | |
| Dec 24, 2018 | ESPR Esperion Therapeutics, Inc. | 10% Owner | Buy | 50,000 | $39.91 | $1,995,725.00 | +1.5% | |
| Dec 17, 2018 | ESPR Esperion Therapeutics, Inc. | 10% Owner | Buy | 60,000 | $47.73 | $2,864,070.00 | +1.8% | |
| Aug 3, 2018 | ESPR Esperion Therapeutics, Inc. | 10% Owner | Buy | 50,000 | $46.14 | $2,306,970.00 | +1.5% | |
| Jul 12, 2018 | ESPR Esperion Therapeutics, Inc. | 10% Owner | Buy | 50,000 | $41.77 | $2,088,300.00 | +1.6% | |
| Jun 29, 2018 | ESPR Esperion Therapeutics, Inc. | 10% Owner | Buy | 50,000 | $39.48 | $1,973,805.00 | +1.6% | |
| Jun 21, 2018 | ESPR Esperion Therapeutics, Inc. | 10% Owner | Buy | 60,000 | $38.57 | $2,314,224.00 | +2.0% | |
| Jun 7, 2018 | ESPR Esperion Therapeutics, Inc. | 10% Owner | Buy | 60,000 | $37.79 | $2,267,292.00 | +2.0% |